Additionally, IFN-γ and IFN-β regulate ceramide metabolism [74]; the levels of ceramide are considered as a biomarker of insulin resistance and obesity. This evidence concerns the gene IFNB1 and obesity due to melanocortin 4 receptor deficiency.